The Food and Drug Administration announced on Friday that it “will be quick to get an emergency approval for Pfizer and BioNTech’s coronavirus vaccine.”
3 min read
This article has been translated from our English edition.
This story originally appeared on Business Insider
The US Food and Drug Administration has announced that it will license the COVID-19 vaccine from Pfizer and BioNTech.
He said Friday morning that he would “work quickly towards getting the injection completed and issued an emergency permit”. The COVID-19 vaccine would be the first to be approved for use in the United States.
The FDA said it had notified drug manufacturers, as well as the Centers for Disease Control and Prevention and the federal vaccine initiative known as Operation Warp Speed, so that they can “implement their plans for the timely distribution of” the vaccine. “
The vaccine could be launched on Monday, Health and Welfare Minister Alex Azar said on Friday morning Good morning America.
NEW: FDA will approve the Pfizer-BioNTech COVID-19 coronavirus vaccine according to HHS Azar. The vaccinations could already be given on Monday or Tuesday of the next week. https://t.co/v1dsjMAvCK pic.twitter.com/48CGRJRTVs
– Good morning America (@GMA) December 11, 2020
“We could see people getting vaccinated on Monday Tuesday next week,” said Azar.
The announcement follows confirmation from an independent panel of experts of more than 20 leading scientists and doctors who on Thursday reviewed data from a vaccine study with Pfizer and BioNTech.
Those responsible for Operation Warp Speed have already announced that they will be sending 2.9 million doses of the vaccine in a few days.
The United States expects to vaccinate 100 million people by March: 20 million in December, 30 million in January, and 50 million more in February. Those projections depend on the sourcing of vaccines from Pfizer and Moderna, a biotech company that also has a highly potent injection that is under review by the FDA.
Federal agencies assign vaccination doses to states and territories based on their adult population, with each state deciding how to distribute its supply. Earlier this month, a CDC advisory group recommended that healthcare workers and nursing home residents should be on the front lines.
However, a key COVID-19 adviser to President-elect Joe Biden has warned Americans to expect “problems” with the launch of the Pfizer and BioNTech vaccine.
“The biggest challenge will be to produce it and then put it in people’s arms,” said Dr. Atul Gawande on Thursday.
The UK began administering the Pfizer and BioNTech vaccine on Tuesday, becoming the first nation in the West to introduce a COVID-19 vaccine. The next day, Canada became the second western country to approve the vaccine.